» Articles » PMID: 31121901

Nuclear Phospho-SOD1 Protects DNA from Oxidative Stress Damage in Amyotrophic Lateral Sclerosis

Overview
Journal J Clin Med
Specialty General Medicine
Date 2019 May 25
PMID 31121901
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

We already demonstrated that in peripheral blood mononuclear cells (PBMCs) of sporadic amyotrophic lateral sclerosis (sALS) patients, superoxide dismutase 1 (SOD1) was present in an aggregated form in the cytoplasmic compartment. Here, we investigated the possible effect of soluble SOD1 decrease and its consequent aggregation. We found an increase in DNA damage in patients PBMCs characterized by a high level of aggregated SOD1, while we found no DNA damage in PBMCs with normal soluble SOD1. We found an activation of ataxia-telangiectasia-mutated (ATM)/Chk2 and ATM and Rad3-related (ATR)/Chk1 DNA damage response pathways, which lead to phosphorylation of SOD1. Moreover, data showed that phosphorylation allows SOD1 to shift from the cytoplasm to the nucleus, protecting DNA from oxidative damage. Such pathway was finally confirmed in our cellular model. Our data lead us to suppose that in a sub-group of patients this physiologic pathway is non-functional, leading to an accumulation of DNA damage that causes the death of particularly susceptible cells, like motor neurons. In conclusion, during oxidative stress SOD1 is phosphorylated by Chk2 leading to its translocation in the nuclear compartment, in which SOD1 protects DNA from oxidative damage. This pathway, inefficient in sALS patients, could represent an innovative therapeutic target.

Citing Articles

Pathological Involvement of Protein Phase Separation and Aggregation in Neurodegenerative Diseases.

Wu Y, Ma B, Liu C, Li D, Sui G Int J Mol Sci. 2024; 25(18).

PMID: 39337671 PMC: 11432175. DOI: 10.3390/ijms251810187.


Nuclear Localization of Human SOD1 in Motor Neurons in Mouse Model and Patient Amyotrophic Lateral Sclerosis: Possible Links to Cholinergic Phenotype, NADPH Oxidase, Oxidative Stress, and DNA Damage.

Martin L, Koh S, Price A, Park D, Kim B Int J Mol Sci. 2024; 25(16).

PMID: 39201793 PMC: 11354607. DOI: 10.3390/ijms25169106.


Aberrant protein aggregation in amyotrophic lateral sclerosis.

Wang H, Zeng R J Neurol. 2024; 271(8):4826-4851.

PMID: 38869826 DOI: 10.1007/s00415-024-12485-z.


poly(PR) mediated neurodegeneration is associated with nucleolar stress.

Cicardi M, Hallgren J, Mawrie D, Krishnamurthy K, Markandaiah S, Nelson A iScience. 2023; 26(9):107505.

PMID: 37664610 PMC: 10470315. DOI: 10.1016/j.isci.2023.107505.


Molecular Chaperones' Potential against Defective Proteostasis of Amyotrophic Lateral Sclerosis.

Kinger S, Dubey A, Kumar P, Jagtap Y, Choudhary A, Kumar A Cells. 2023; 12(9).

PMID: 37174703 PMC: 10177248. DOI: 10.3390/cells12091302.


References
1.
Friedberg E . DNA damage and repair. Nature. 2003; 421(6921):436-40. DOI: 10.1038/nature01408. View

2.
Bartek J, Lukas J . Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell. 2003; 3(5):421-9. DOI: 10.1016/s1535-6108(03)00110-7. View

3.
Cova E, Cereda C, Galli A, Curti D, Finotti C, Di Poto C . Modified expression of Bcl-2 and SOD1 proteins in lymphocytes from sporadic ALS patients. Neurosci Lett. 2006; 399(3):186-90. DOI: 10.1016/j.neulet.2006.01.057. View

4.
Sau D, De Biasi S, Vitellaro-Zuccarello L, Riso P, Guarnieri S, Porrini M . Mutation of SOD1 in ALS: a gain of a loss of function. Hum Mol Genet. 2007; 16(13):1604-18. DOI: 10.1093/hmg/ddm110. View

5.
Migliore L, Coppede F . Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases. Mutat Res. 2008; 667(1-2):82-97. DOI: 10.1016/j.mrfmmm.2008.10.011. View